...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: from IR "Hepalink does not own Zenith shares."

,,,,,I doubt it that this team will answer anything presented to them in a truthful way. We know they dont know things and most likely they feed us bologna just to get by in the present. You will get nothing of use from any of it,,just answers which beget more questions which triggers more frustration. Any hard questions will only get silenced,,,,The team is very comfy sitting on thier hands watching third parties do their work. Great downtime if you can find it,,,,,and most likely all working from home,,,,working!!!,,,humm,,,,nahhhhh,,lmao!

Share
New Message
Please login to post a reply